Study on Oxytocin's Effects on Trust and Learning in Healthy Children Using Nasal Spray
- Substances:Oxytocin
Belgium- Participants:0–17 years · Healthy volunteers
- Substances:Oxytocin
- Sponsor:UZ Leuven
Rare diseases
Investigational molecules
Locations
Back to Belgium1 979 clinical trials in Kessel-Lo, Belgium. Every trial is listed in the EU Clinical Trials Register and updated daily.
BelgiumStudy on the Effectiveness and Safety of IMVT-1402 for Adults with Graves' Disease
BelgiumStudy of ibuzatrelvir tablets in non-hospitalized adults and adolescents with COVID-19 who are at high risk of developing severe illness
BelgiumStudy on Long-Term Safety and Efficacy of VX-670 for Adults with Myotonic Dystrophy Type I
BelgiumLong-Term Safety Study of Inhaled Pirfenidone for Patients with Progressive or Idiopathic Pulmonary Fibrosis
BelgiumStudy on Doxycycline for Reducing Bacterial STIs in MSM and TGW with HIV
BelgiumStudy comparing NVL-655 to alectinib in untreated patients with ALK-positive advanced non-small cell lung cancer
Belgium
BelgiumStudy Comparing Sacituzumab Govitecan and Standard Treatment for Patients with Previously Treated Extensive Stage Small Cell Lung Cancer
BelgiumStudy Comparing Rilvegostomig with Fluoropyrimidine and Trastuzumab Deruxtecan to Standard Treatment for Patients with HER2-positive Gastric Cancer
BelgiumStudy of Trastuzumab Deruxtecan and Rilvegostomig for Patients with Advanced HER2-positive Biliary Tract Cancer
BelgiumStudy on Rilzabrutinib for Patients Aged 10-65 with Sickle Cell Disease
BelgiumThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on proton pump inhibitor (PPI) deprescribing strategies for patients with chronic usage patterns. This research explores alternative treatment approaches for common digestive conditions.
The study evaluates various therapeutic approaches, including on-demand medication and alginate-based alternatives, to optimize treatment protocols for patients with digestive disorders.
Research examining optimal medication reduction strategies in primary care settings, with a focus on improving long-term patient outcomes and reducing unnecessary medication use.
This initiative aims to establish evidence-based guidelines for discontinuing long-term medications when they may no longer be clinically indicated.
Comparative research evaluating the effectiveness of different deprescribing approaches in managing common gastrointestinal conditions.
The research compares traditional dose reduction methods with newer therapeutic strategies to determine optimal treatment pathways.
Tell us about your condition – we search every trial in Europe and connect you with the right site.